Actualiteit

Instituto Bernabeu’s medical codirector and the Reproductive and Genetics Guidance Unit, doctor Andrea Bernabeu, participated last Friday, 15th of January in the digital presentation of the United Kingdom’s Society of Medicine.

Specialized scientific magazine “Reproductive BioMedicine Journal” includes in its December 2020 publication an innovative investigation developed by Instituto Bernabeu’s Genetics department.

Precisely because times are tough, now is the right time to invest. Instituto Bernabeu has decided not to put scientific progress on hold as it waits for better times to come. 

Biologists at Instituto Bernabeu Albacete have explained the reproductive medicine clinic’s every dayto the 60 Pharmacy students from the Castilla la Mancha University (UCLM) as part of the clinic’s usual practice.

Rafael Bernabeu Social Fund has maintained its commitment to society in a particularly difficult year where the global pandemic is being devastating.

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Preimplantational Genetic Diagnosis (PGD) or Preimplantational Genetic Test (PGT)

Grupo Instituto Bernabeu achieves in 2020 a new recognition to its excellency solid policy. The institution has been awarded with the QH** two stars Certificate for the health care quality provided given by the Instituto for the Health Progress and Integration (IDIS in Spanish) and recognises excellence in healthcare organisations that understand quality as part of a culture of continuous improvement. Auditor committee has taken this decision after analysing, checking and validating the proofs sent by Grupo Instituto Bernabeu.  

This award values the innovative marketing work, the adaptation capacity, internationalisation and the differentiation between design and communication of the specific pathologies’ treatment.

Instituto Bernabeu’s endocrinologist, Dr Pino Navarro, has taken part of the 9th Ginep Scientific Meeting held in Alicante with the presentation “Pharmacological approach in overweight infertile women.

Instituto Bernabeu’s medical director, doctor Rafael Bernabeu, will address on 12 of November the medical and assistance aspects of the Trans-border Reproductive Medicine.